Hainan Huluwa Pharmaceutical Group Co., Ltd. (605199.SS) SHH

8.85

-0.03(-0.34%)

Updated at December 05 10:25AM

Currency In CNY

Valuation

Market Cap6.34B
Enterprise Value7.09B
P/E Ratio-21.13
PEG Ratio1.56
Price/Sales Ratio3.34
Price/Book Ratio5.15
Enterprise/Revenue4.41
Enterprise/EBITDA-38.7

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.16
Operating Margin-0.15

Management Effectiveness

Return On Assets-0.06
Return On Equity-0.24

Income Statement

Revenue1.41B
Revenue/Share2.66
Gross Profit676.44M
EBITDA-159.6M
Net Income-274.46M
Diluted EPS-0.69

Balance Sheet

Total Cash110.74M
Total Cash/Share0.28
Total Debt1.24B
Total Debt/Equity1.8
Current Ratio0.82
Book Value Per Share1.84

Price History

52-Week Change-64.71
52-Week High24.15
52-Week Low8.18
Moving Average 50 Days9.22
Moving Average 200 Days10.75

Statistics

Average Volume5.17M
Shares Outstanding400.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.16
Last Split FactorN/A
Last Split DateN/A